PROCEPT BioRobotics (PRCT) Receivables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Receivables data on file, last reported at $96.4 million in Q1 2026.

• Quarterly Receivables rose 21.6% year-over-year to $96.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.4 million (up 21.6% YoY) and the FY2025 annual result came in at $83.5 million, changed 0.04% from the prior year.
• Receivables rose to $96.4 million in Q1 2026 per PRCT's latest filing, from $83.5 million in the prior quarter.
• Across five years, Receivables topped out at $96.4 million in Q1 2026 and bottomed at $7.0 million in Q1 2022.
• The 5-year median for Receivables is $56.1 million (2024), against an average of $51.5 million.
• The widest annual swing landed in 2022, when Receivables soared 242.11%; it then climbed 0.04% in 2025.
• Tracing PRCT's Receivables over 5 years: stood at $15.3 million in 2022, then surged by 216.76% to $48.4 million in 2023, then jumped by 72.6% to $83.5 million in 2024, then gained by 0.04% to $83.5 million in 2025, then advanced by 15.39% to $96.4 million in 2026.
• Per Business Quant, the three latest PRCT Receivables figures stand at $96.4 million (Q1 2026), $83.5 million (Q4 2025), and $84.5 million (Q3 2025).

Peer Comparison